You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

艾迪康(09860.HK)引進Guardant Health液體活檢產品

阿思達克 09-25 17:45
艾迪康(09860.HK)宣布,引進腫瘤精準醫療企業Guardant Health的液體活檢產品,以加速中國臨床研究和腫瘤新藥開發。 據悉,艾迪康在其全資子公司上海錦測醫學檢驗所進行全面基因組測序分析(CGP)。